RxDoctor Payments Data

Raymond Halstead

Family · Pensacola, FLNPI 1548742927

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $35,000 of the $50,091 with a category attached, or 69.9%. AbbVie accounts for 94.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $14,977 and has fallen 75.6% since, to $3,662 in 2025. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,091in general payments, 2019–2025

Across 243 payments — averaging $206.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$47K
  • Insmed, Inc.$720
  • Melinta Therapeutics, LLC$453
  • Merck$415
  • Paratek Pharmaceuticals, Inc.$395
  • Viiv Healthcare Company$239
  • plus $572 from 15 others

What the payments were for

  • Speaking & faculty fees$35,00070%
  • Travel & lodging$10,35321%
  • Food & beverage$4,7069%
  • Education$320%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,091 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$71,505
Medicare patients
185
Services billed
74,369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vancomycin Hcl61$10,279
Piperacillin-TazobactamPiperacillin Sodium/Tazobactam47$5,912
Cefepime Hcl53$5,783
Daptomycin28$4,967
CeftriaxoneCeftriaxone Sodium37$3,915
Meropenem32$3,622
Sodium Chloride0.9 % Sodium Chloride33$737
Cefazolin Sodium15$584
Doxycycline Hyclate32$392
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$286
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$226
Fluconazole13$216
Levofloxacin14$77

Paid to pharmacies, not to this prescriber.

Other family in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →